Position in ABBV
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$15,024,166
+$2,409,094 QoQ
Shares Held
59,705
+2.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.16%
of 13F equity value
Holder Rank
#740
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 17%
Shared 0%
None 83%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Mar 31, 2021CallValue
$10,822
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOTH FINANCIAL ADVISORY CORP holds $48,675,880 across 11 Drug Manufacturers - General names. ABBV ranks #2 (30.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
63,494 | $16,125,571 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
59,705 | $15,024,166 | |
| 3 | AMGN |
Amgen Inc
|
28,421 | $10,291,812 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
97,037 | $5,591,271 | |
| 5 | LLY |
ELI LILLY & Co
|
1,207 | $1,447,712 | |
| 6 | PFE |
Pfizer Inc
|
4,200 | $101,136 | |
| 7 | MRK |
Merck & Co., Inc.
|
539 | $69,261 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
117 | $14,781 |
All Filings in ABBV
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,024,166 | 59,705 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $12,615,072 | 58,003 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $11,717,424 | 51,282 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $11,109,752 | 47,982 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $8,397,077 | 45,238 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $8,833,782 | 42,162 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $7,092,184 | 39,911 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $7,702,707 | 39,005 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $6,690,137 | 39,005 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $7,021,047 | 38,556 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $5,995,479 | 38,688 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $5,743,579 | 38,532 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $5,617,567 | 41,695 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $7,720,998 | 48,447 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $8,684,759 | 53,739 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $7,595,480 | 56,594 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $9,312,434 | 60,802 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $12,294,098 | 75,838 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $11,980,869 | 88,485 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $8,974,891 | 83,201 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $9,180,272 | 81,501 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $8,717,662 | 80,555 | Shares | Sole | 2021-04-20 | |
| 2021-03-31 | $10,822 | 100 | Call | Sole | 2021-04-20 | |
| 2020-12-31 | $8,941,453 | 83,448 | Shares | Sole | 2021-01-25 | |
| 2020-12-31 | $21,430 | 200 | Call | Sole | 2021-01-25 | |
| 2020-09-30 | $6,534,301 | 74,601 | Shares | Sole | 2020-10-16 | |
| 2020-09-30 | $17,518 | 200 | Call | Sole | 2020-10-16 | |
| 2020-06-30 | $7,337,678 | 74,737 | Shares | Sole | 2020-07-14 | |
| 2020-06-30 | $19,636 | 200 | Call | Sole | 2020-07-14 | |
| 2020-03-31 | $4,121,269 | 54,092 | Shares | Sole | 2020-04-20 | |
| 2020-03-31 | $7,619 | 100 | Call | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||